Well, it is hogwash. And it's particularly hogwash because among those various reforms that you've itemized there, let's reflect on how much persuasion, how much public argument was required to even bring the President of the United States to go along with repealing this egregious, superfluous 1099 obligation. We had to make the public argument. We had to win the argument because there was great reluctance, if recollection serves, and I think it does, to make any changes whatsoever to what most Americans now know as ObamaCare. The thought was and the thinking still seems to be among a number of our colleagues that if they touch the act, then that is going to lead to further reform, perhaps dissolution or repeal of the act altogether and replacement with something that is more patient centered, with something, frankly, that is more bipartisan. So to our colleagues who often level criticisms at those of us who are identifying ways to alleviate the pain on the American people with respect to this law, the so-called Affordable Care Act, I think it bears reminding the importance of continuing the argument, forcefully making the argument about all the pain that it is causing.
Todd Young: “Well, it is hogwash. And it's particularly hogwash because among those various reforms that you've itemized there, let's…”
On the recordAugust 1, 2013
Share
More from Todd Young
Aug 10, 2026
One could imagine this issue being broadly bipartisan as well at a time when people rightly question whether there are just basic good government measures that we can take across party lines that majorities can agree to.
Aug 14, 2026
I’m told we’re pretty close, and you know, listen, we need to come together for the good of our rural communities and give them the risk management programs and the other basic programs that are required to feed the world.
Jul 31, 2026
“America’s long-term economic strength depends on our ability to turn innovation into opportunity,” said Senator Young.
Aug 30, 2026
However, China’s rise in biotechnology and the growing risks of antimicrobial resistance present new challenges to the United States.





